Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

CVS HEALTH CORP (CVS)

2K + Investors. Track Smart Money conviction in CVS. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -58
Streak
1Q ▼
Buyers last Q
48%

Smart Money Signals — CVS

Based on 1870 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds reduced or closed their CVS positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
📊

High ownership — 88% of 3.0Y peak

88% of all-time peak
1,870 funds currently hold this stock — 88% of the 3.0-year high of 2,114 funds (reached 2023 Q4). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
📶

Steady growth — +8% more funds vs a year ago

fund count last 6Q
+143 new funds entered over the past year (+8% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟠

More sellers than buyers — 48% buying

912 buying999 selling
Last quarter: 999 funds reduced or exited vs 912 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.
⚠️

Fewer new buyers each quarter (-92 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 199 → 220 → 271 → 179. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
🔒

71% of holders stayed for 2+ years

■ 71% conviction (2yr+) ■ 15% medium ■ 14% new
1,333 out of 1,870 hedge funds have held CVS for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
➡️

Steady discovery — ~179 new funds/quarter

290 → 199 → 220 → 271 → 179 new funds/Q
New funds entering each quarter: 199 → 220 → 271 → 179. Consistent flow of new institutional buyers without clear acceleration or slowdown.
🏛️

Deep conviction — 75% of holders stayed 2+ years

■ 75% veterans ■ 8% 1-2yr ■ 17% new
Of 1,949 current holders: 1,462 (75%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.
🏆

Elite ownership — 56% AUM from top-100 funds

56% from top-100 AUM funds
69 of 1870 holders are among the 100 largest funds by AUM, controlling 56% of total institutional value in CVS. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
3.0
out of 10
Low Exit Risk
Exit risk score 3.0/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — CVS

In 2026 Q1, 912 hedge funds were net buyers of CVS (179 opened a new position, 733 added to an existing one), while 999 reduced or exited (762 trimmed, 237 sold completely) — a 48% buyer ratio, indicating roughly balanced activity. 56% of total institutional value in CVS is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: -58 funds (more exits than new entries). Total institutional holders: 1870.

Hedge Fund Ownership: CVS

How many hedge funds hold CVS — quarterly history vs. share price
Quarterly hedge fund ownership of CVS vs. share price

Market Analysis: CVS

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: CVS

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy CVS HEALTH CORP (CVS) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much CVS has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 70d ago
CVS
+41.1%
XLV
+4.1%

CVS outperformed XLV by +37.0% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 25d ago
CVS
+1.2%
XLV
+5.2%

Since the filing became public, CVS outperformed XLV by -4.0% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Broad Consensus, Selective Conviction

Many quality funds hold this stock, but top-tier positions remain relatively small.

83 top-rated funds 10 high-conviction
Consensus
8.4
/ 10
breadth
×
Elite
5.2
/ 10
conviction
Hedge Fund Positioning: CVS
2K + Investors

Track Smart Money conviction in CVS. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 1858 1928 -3.63%
13F Shares 1.10B 1.17B -5.87%
Total Value $75.77B $91.22B -16.94%
New Positions 176 271 -95
Increased Positions 711 687 +24
Closed Positions 246 153 +93
Reduced Positions 735 723 +12
Total Calls 42 38 10.53%
Total Puts 46 41 12.2%
PUT/CALL Ratio 1.1 1.08 Neutral

Statistics: CVS

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

2K + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in CVS. Verified SEC 13F-HR filings.

QUARTER:
Top 25 institutional holders of CVS — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 GLENVIEW CAPITAL MANAGEMENT, LLC 14.78% 8,196,799 $588.7M
2 FAIRFAX FINANCIAL HOLDINGS LTD/ CAN 10.03% 2,712,000 $194.8M
3 Watchtower Advisors, LP 9.29% 182,357 $13.1M
4 Solel Partners LP 7.58% 493,700 $35.5M
5 Kiltearn Partners LLP 7.05% 365,068 $26.2M
6 Chieftain Capital Management, Inc. 6.90% 3,875 $209K
7 Strategic Planning, Inc. 5.27% 146,342 $10.5M
8 OSLO PENSJONSFORSIKRING AS 5.00% 447,471 $32.1M
9 Employees Provident Fund Board 4.31% 971,566 $100.8M
10 COLRAIN CAPITAL LLC 4.14% 148,954 $10.7M
11 DAVIS SELECTED ADVISERS 4.04% 12,239,666 $879.1M
12 EDGAR LOMAX CO/VA 3.67% 715,960 $51.4M
13 Alexander Randolph Advisory, Inc. 3.58% 57,822 $4.2M
14 Patient Capital Management, LLC 3.56% 1,357,159 $97.5M
15 Hillman Capital Management, Inc. 3.36% 67,462 $4.8M
16 PZENA INVESTMENT MANAGEMENT LLC 3.21% 13,773,053 $989.2M
17 Permit Capital, LLC 3.06% 125,500 $9.0M
18 Polaris Capital Management, LLC 3.04% 517,700 $37.2M
19 Atle Fund Management AB 2.99% 23,773 $9.3M
20 Rhenman & Partners Asset Management AB 2.98% 336,500 $24.2M
21 Value Partners Investments Inc. 2.96% 539,973 $38.8M
22 Parkman Healthcare Partners LLC 2.87% 387,306 $27.8M
23 Hamlin Capital Management, LLC 2.85% 1,642,646 $118.0M
24 Long Focus Capital Management, LLC 2.74% 1,450,200 $104.2M
25 Henshaw Capital LLC 2.65% 213,000 $20.4M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — CVS HEALTH CORP (CVS)

What does the Smart Money Trend signal show for CVS?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their CVS positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for CVS?

More sellers than buyers — 48% buying: Last quarter: 999 funds reduced or exited vs 912 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

What is the fund quality score for CVS holders?

Elite ownership — 56% AUM from top-100 funds: 69 of 1870 holders are among the 100 largest funds by AUM, controlling 56% of total institutional value in CVS. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held CVS?

71% of holders stayed for 2+ years: 1,333 out of 1,870 hedge funds have held CVS for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy CVS HEALTH CORP (CVS) following the 2026 Q1 hedge fund 13F filings?

As of today, CVS has moved +1.2% since the 2026 Q1 13F filing date (May 15, 2026), compared to +5.2% for the XLV sector ETF — an outperformance of -4.0%. Since the quarter end (March 31, 2026), CVS has gained +41.1% vs +4.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →